Sensus Healthcare Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
107.60
3,699.50
237.30
346.40
3,710.50
2,022.80
Depreciation, Depletion & Amortization
265.60
272.60
315.60
337.60
387.90
658.30
Other Funds
-
-
-
-
289.30
1,091.20
Funds from Operations
552.10
3,223.70
93.10
750.40
2,487.70
273.40
Changes in Working Capital
680.70
1,356.00
1,432.40
1,601.40
568.90
8,290.40
Net Operating Cash Flow
128.70
1,867.70
1,339.30
851.00
3,056.60
8,563.70
Capital Expenditures
251.00
124.00
196.20
286.00
287.60
Purchase/Sale of Investments
-
-
-
7,566.10
6,461.50
Net Investing Cash Flow
251.00
124.00
196.20
7,852.10
6,173.90
Cash Dividends Paid - Total
-
45.40
-
2,552.70
-
Issuance/Reduction of Debt, Net
-
-
47.70
422.70
2,215.00
Net Financing Cash Flow
3,245.90
45.40
2,061.90
8,680.60
1,925.70
Net Change in Cash
2,866.20
2,037.10
526.40
22.60
5,043.00
Free Cash Flow
379.70
1,991.60
1,535.50
1,137.00
3,344.20
Change in Capital Stock
3,245.90
-
2,014.20
11,656.00
-

About Sensus Healthcare

View Profile
Address
851 Broken Sound Parkway NW
Boca Raton Florida 33487
United States
Employees -
Website http://www.sensushealthcare.com
Updated 07/08/2019
Sensus Healthcare, Inc. engages in the design, manufacture, and marketing of proprietary medical devices specializing in the treatment of non-melanoma skin cancers and other skin conditions. Its main product is SRT-100, a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating basal cell and squamous cell skin cancers and other skin conditions such as keloids. The company was founded by Joseph C.